-
Researchers at the Center for Cell-Based Therapy (CTC), USA, have discovered a set of biomarkers that can be used to predict which patients diagnosed with glioblastoma, an aggressive form of brain cancer, may have tumours that are more resistant to radiation therapy.
The discovery, published in the journal Frontiers in Oncology, can help doctors choose the treatment that should enable patients to live longer.
Gliomas are graded on a scale of one to four.
Grade four gliomas are the most [...]
-
Researchers at the Center for Cell-Based Therapy (CTC) have discovered a set of biomarkers that can be used to predict which patients diagnosed with glioblastoma, an aggressive form of brain cancer, may have tumors that are more resistant to radiation therapy. The discovery, published in the journal Frontiers in Oncology, can help doctors choose the treatment that should enable patients to live longer.
Gliomas are graded on a scale of one to four. Grade four gliomas are the most aggressive and [...]
-
Researchers at the Center for Cell-Based Therapy (CTC) have discovered a set of biomarkers that can be used to predict which patients diagnosed with glioblastoma, an aggressive form of brain cancer, may have tumors that are more resistant to radiation therapy. The discovery, published in the journal Frontiers in Oncology, can help doctors choose the treatment that should enable patients to live longer.
Gliomas are graded on a scale of one to four. Grade four gliomas are the most aggressive and [...]
-
Researchers at the Center for Cell-Based Therapy (CTC) have discovered a set of biomarkers that can be used to predict which patients diagnosed with glioblastoma, an aggressive form of brain cancer, may have tumours that are more resistant to radiation therapy.
The discovery, published in the journalFrontiers in Oncology, can help doctors choose the treatment that should enable patients to live longer.
Gliomas are graded on a scale of one to four.
Grade four gliomas are the most aggressive [...]
-
Researchers at the Center for Cell-Based Therapy (CTC) have discovered a set of biomarkers that can be used to predict which patients diagnosed with glioblastoma, an aggressive form of brain cancer, may have tumors that are more resistant to radiation therapy. The discovery, published in the journal Frontiers in Oncology, can help doctors choose the treatment that should enable patients to live longer.
Gliomas are graded on a scale of one to four. Grade four gliomas are the most aggressive and [...]
-
Investigadores del Centro de Terapia Celular (CTC) de Brasil descubrieron un conjunto de biomarcadores capaz de señalar qué pacientes diagnosticados con un tipo agresivo de cáncer cerebral (glioma) tendrían tumores con mayor resistencia a la radioterapia. Este descubrimiento, publicado en la revista Frontiers in Oncology, puede ayudarles a los médicos en la decisión sobre el tratamiento más indicado y con mejor pronóstico de sobrevida para [...]
-
Maria Fernanda Ziegler | Agência FAPESP – Pesquisadores do Centro de Terapia Celular (CTC) descobriram um conjunto de biomarcadores capaz de indicar quais pacientes diagnosticados com um tipo agressivo de câncer cerebral (glioma) teriam tumores com maior resistência à radioterapia. A descoberta, publicada na revista Frontiers in Oncology , pode auxiliar médicos na decisão sobre o tratamento mais indicado e com melhor prognóstico de [...]
-
Pesquisadores do Centro de Terapia Celular (CTC) descobriram um conjunto de biomarcadores capaz de indicar quais pacientes diagnosticados com um tipo agressivo de câncer cerebral (glioma) teriam tumores com maior resistência à radioterapia. A descoberta, publicada na revista Frontiers in Oncology , pode auxiliar médicos na decisão sobre o tratamento mais indicado e com melhor prognóstico de sobrevida para os pacientes.
O glioma é o mais comum e [...]
-
Saense
- Publicado em 28 de julho de 2021
Estudo conduzido por pesquisadores do Centro de Terapia Celular identificou assinatura genética que pode servir como subsídio para uma potencial triagem de pacientes que devem ou não ser submetidos à radioterapia
Pesquisadores do Centro de Terapia Celular (CTC) descobriram um conjunto de biomarcadores capaz de indicar quais pacientes diagnosticados com um tipo agressivo de câncer cerebral (glioma) teriam tumores com maior resistência à [...]
-
Estudo conduzido por pesquisadores do Centro de Terapia Celular identificou assinatura genética que pode servir como subsídio para uma potencial triagem de pacientes que devem ou não ser submetidos à radioterapia
Pesquisadores do Centro de Terapia Celular (CTC) descobriram um conjunto de biomarcadores capaz de indicar quais pacientes diagnosticados com um tipo agressivo de câncer cerebral (glioma) teriam tumores com maior resistência à [...]
